Corrigendum to: Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease
Corrigendum to: Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease [Cardiovasc Res 2020; oi:10.1093/cvr/cvaa100]
Source: Cardiovascular Research - Category: Cardiology Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Heart | Peripheral Vascular Disease (PVD) | Women